CHSwitzerlandEarnings
Novartis third-quarter 2026 results, Basel
Novartis reports Q3 from Basel with a media and analyst briefing. Growth-driver sales and the response to looming US patent expiries are the story, and the print typically sets the tone for European pharma that week.
- News
- 3/5
- Markets
- 3/5
- Overall
- 3/5

